24
2
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T60490 | Melatonin receptor agonist 1 | ||
Melatonin receptor agonist 1 (compound 20c) is a potent agonist of melatonin receptor (MT) with Ki values of 108 nM for MT2 and 1140 nM for MT 1 [1]. | |||
T14042 | 4-P-PDOT | 4-phenyl-2- propionamidotetralin | Melatonin Receptor , MT Receptor |
4-P-PDOT (4-phenyl-2- propionamidotetralin) is a potent, selective and affinity Melatonin receptor (MT2) antagonist. | |||
T9193 | ACH-000143 | Melatonin Receptor , MT Receptor | |
ACH-000143 have been identified as a novel agonist of the melatonin receptors MT1 and MT2. | |||
T8600 | N-ACETYLTRYPTAMINE | Melatonin Receptor | |
N-ACETYLTRYPTAMINE is a partial agonist for melatonin receptors in the retina. Also used for determination of serotonin N-acetyl transferase. | |||
T1445 | Agomelatine | Thymanax,S-20098,Valdoxan | Melatonin Receptor , 5-HT Receptor |
Agomelatine (Valdoxan) is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression. | |||
T1463 | Ramelteon | TAK-375 | Melatonin Receptor , MT Receptor |
Ramelteon (TAK-375) is a Melatonin Receptor Agonist. The mechanism of action of ramelteon is as a Melatonin Receptor Agonist. | |||
T15795 | Luzindole | N-0774 | Melatonin Receptor , MT Receptor |
Luzindole (N-0774) is a selective melatonin receptor antagonist. Luzindole inhibits experimental autoimmune encephalomyelitis and exerts antidepressant-like activity. Luzindole preferentially targets MT2 (Mel1b) over MT1... | |||
T3495 | Tasimelteon | VEC-162,BMS-214778 | Melatonin Receptor , MT Receptor |
Tasimelteon (BMS-214778) is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals. | |||
T16834 | S26131 | N-[2-[7-[3-[8-(2-acetamidoethyl)naphthalen-2-yl]oxypropoxy]naphthalen-1-yl]ethyl]acetamide | MT Receptor |
S26131 (N-[2-[7-[3-[8-(2-acetamidoethyl)naphthalen-2-yl]oxypropoxy]naphthalen-1-yl]ethyl]acetamide) behaves as an antagonist on MT1 and MT2 receptors with Ki of 0.5 and 112 nM respectively. | |||
T22530 | 6-Chloromelatonin | Melatonin Receptor , Dopamine Receptor | |
6-Chloromelatonin is a potent melatonin receptor agonist, a 5-methoxyindole compound that competes for the same presynaptic melatonin receptor sites in the rabbit retina and inhibits the calcium-dependent release of [3H]... | |||
T10929L | D-3263 hydrochloride | EC D-3263 HCl,D3263 HCl salt | TRP/TRPV Channel |
D-3263 hydrochloride (D3263 HCl salt) is enteric-coated, orally bioavailable transient receptor potential melatonin member 8 (TRPM8) agonist. | |||
T10073 | 2-Iodomelatonin | Melatonin Receptor | |
2-Iodomelatonin is a potent agonist of melatonin receptor 1 (MT1) with a Ki value of 28 pM, it is more 5-fold selective for MT1 over MT2. 2-iodomelatonin can be used to identify, characterize and localize melatonin bind... | |||
T10198 | 8-M-PDOT | 8-Methoxy-2-propionamidotetralin,AH-002 | MT Receptor |
8-M-PDOT (AH-002) is a selective and potent melatonin MT2 receptor agonist that also inhibits MT1 receptors.8-M-PDOT has anxiolytic activity and may be used to study MT2-induced neuropathic pain. | |||
T28644 | S20928 | S 20928,S-20928 | |
S20928 is an antagonist of melatonin receptor. | |||
T28645 | S-22153 | ||
S22153 is an antagonist of melatonin receptor. | |||
T29044 | UCM 765 | UCM-765,UCM765 | |
UCM 765 is a partial agonist of melatonin MT(2) receptor. | |||
T69409 | DH-97 | ||
DH-97 is a potent MT2 melatonin receptor antagonist (pKi value = 8.03). | |||
T22721 | DH97 | DH 97 | Others |
MT2 melatonin receptor antagonist | |||
T27430 | GR 196429 | GR-196429,GR 196,429,GR-196,429,GR196429,GR196,429 | |
GR 196429, a melatonin receptor agonist, exhibits selectivity for the MT1 subtype. This compound not only promotes sleep and alters circadian rhythms but also stimulates melatonin release in mice. | |||
T27429 | GR 128107 | GR128107,GR-128107 | |
GR 128107 is an antagonist of melatonin receptor. | |||
T10929 | D-3263 | Others | |
D-3263 is an agonist of transient receptor potential melatonin member 8 (TRPM8) with potential antitumor activity. | |||
T17095 | TIK-301 | PD-6735,LY-156735 | 5-HT Receptor |
TIK-301 is a chlorinated melatonin derivative and a potent, high-affinity, and orally active melatonin MT1 and MT2 receptors agonist (Kis: 0.081 nM and 0.042 nM, respectively). TIK-301 is also a 5-HT2B/5-HT2C receptor an... | |||
T71963 | (−)-WIN 55,212-3 mesylate | ||
(−)-WIN 55,212-3 mesylate is an aminoalkylindole derivative which acts as a competitive neutral antagonist of the human cannabinoid CB2 receptor, blocking both the stimulating action of CP 55,940 and the inverse agonism ... | |||
T70035 | Tasimelteon-d5 | ||
Tasimelteon-d5 is intended for use as an internal standard for the quantification of tasimelteon by GC- or LC-MS. Tasimelteon is a melatonin (MT) receptor agonist. It selectively binds MT1 and MT2 receptors over a panel ... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1659 | Melatonin | Melatonine,N-Acetyl-5-methoxytryptamine | CaMK , Apoptosis , Mitophagy , Estrogen/progestogen Receptor , Melatonin Receptor , Glutathione Peroxidase , Endogenous Metabolite , ROR , Autophagy |
Melatonin (Melatonine) is a biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin... | |||
T1354 | N-Acetyl-5-hydroxytryptamine | Normelatonin,O-Demethylmelatonin,N-Acetylserotonin | Trk receptor , Endogenous Metabolite |
N-Acetyl-5-hydroxytryptamine (O-Demethylmelatonin) , also known as Normelatonin, is the immediate precursor of melatonin. It is produced from serotonin by the enzyme aralkylamine N-acetyltransferase and is converted to m... |
Cat No. | Product Name | ||
---|---|---|---|
L3300 | Histamine & Melatonin Receptor-Targeted Compound Library | 155 compounds | |
A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; |